Venkata S. Bollimpelli

T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers

Prabhu S. Arunachalam, Tysheena P. Charles, Vineet Joag et al. · Nature Medicine · 2020 · 170 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Neuroprotective effect of curcumin-loaded lactoferrin nano particles against rotenone induced neurotoxicity

Venkata S. Bollimpelli, Prashant Kumar, Sonali Kumari et al. · Neurochemistry International · 2016 · 121 citations

Pharmacy, Neuroscience, Pharmacology +16

SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung

Nanda Kishore Routhu, Narayanaiah Cheedarla, Venkata S. Bollimpelli et al. · Nature Communications · 2021 · 97 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs

Nanda Kishore Routhu, Narayanaiah Cheedarla, Sailaja Gangadhara et al. · Immunity · 2021 · 91 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection

Tysheena P. Charles, Samantha L. Burton, Prabhu S. Arunachalam et al. · PLoS Pathogens · 2021 · 36 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15